Express Pharma
Express Pharma, originally known as Express Pharma Pulse since its launch in 1994, is now the top business magazine in India dedicated to the pharmaceutical sector. Thanks to the support of its audience, Express Pharma has established itself as the leading source for business news in the industry. The magazine covers a variety of topics, including news, opinions, analyses, and interviews, organized into four key categories: Market (focusing on the pharmaceutical business), Management (providing insights for pharma management), Research (offering expertise in drug development), and Pharma Life (addressing HR concerns in the pharmaceutical field). Additionally, we publish special editions such as the quarterly Pharma Technology Review, Packaging Special, and LABNEXT.
Outlet metrics
Global
#636475
India
#51065
Health/Biotechnology and Pharmaceuticals
#28
Articles
-
1 week ago |
expresspharma.in | Viveka Roychowdhury
Share India may today account for less than 2–3 per cent of the pharma CDMO market today but has the potential to grow from $3.5 billion to $25 billion.
-
1 week ago |
expresspharma.in | Viveka Roychowdhury
Share There is growing concern that a sizable proportion of medicines in India could be unsafe for patients. For example, on April 19, 2025, CDSCO published three lists of Not of Standard Quality (NSQ) drug alerts for March 2025, spanning 131 product batches. The most common reason cited is failing the dissolution test as per IP 2022.
-
1 month ago |
expresspharma.in | Viveka Roychowdhury
Share With close to three decades of experience in setting up logistics parks at ports, across MENA and India, you have seen the evolution of pharma logistics. What are the key drivers for the current transformation of the pharma and medical device logistics sector in India? And where do free trade warehousing zones (FTWZs) fit into these business imperatives?
-
1 month ago |
expresspharma.in | Viveka Roychowdhury
Share Give a short background of the founders IntegriMedical is led by a team of experienced professionals with a strong background in medical technology, business development and healthcare innovation. The key leadership team includes myself, Ankur Naik, MD, Scott McFarland, CEO and Mark Timm, COO.
-
1 month ago |
expresspharma.in | Viveka Roychowdhury
Share On April 2, US President Trump is expected to follow through on his threats to impose 25 per cent tariffs on drug imports from India. And even if the tariff announcements are deferred or lower than expected, the US Trade Representative (US TR)’s latest report gives some clues that the re-calibration indicated by President Trump will continue.
Express Pharma journalists
Contact details
Address
123 Example Street
City, Country 12345
Phone
+1 (555) 123-4567
Contact Forms
Contact Form
Website
http://expresspharma.inTry JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →